secondary progressive multiple sclerosis

Showing 1 - 25 of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Mayzent Onboarding of Secondary Progressive Multiple Sclerosis

Completed
  • Secondary Progressive Multiple Sclerosis
    • Camperdown, New South Wales, Australia
    • +1 more
    Apr 19, 2023

    Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

    Recruiting
    • Relapsing Multiple Sclerosis
    • +2 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • Best Available Therapy (BAT)
    • Palo Alto, California
    • +20 more
    Jan 25, 2023

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Birmingham, Saint Louis (Glycemic

    Not yet recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • Glycemic load
    • +2 more
    • Birmingham, Alabama
    • +1 more
    Jan 4, 2023

    Secondary Progressive Multiple Sclerosis Trial in Germany (BAF312, Baseline disease modifying therapies (DMTs))

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • BAF312
    • Baseline disease modifying therapies (DMTs)
    • Mittweida, Sachsen, Germany
    • +9 more
    Aug 9, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

    Active, not recruiting
    • Primary Progressive Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • ATA188
    • Placebo
    • La Jolla, California
    • +33 more
    Jul 21, 2022

    Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Ferumoxytol infusion
    • +2 more
    • Salt Lake City, Utah
      University of Utah Health Imaging and Neurosciences Center
    Jun 22, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
    • Placebo oral tablet identical to metformin, up to 4 tablets a day
    • Los Angeles, California
      University of California, Los Angeles
    May 2, 2022

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Glostrup, Copenhagen, Denmark
    • +11 more
    May 3, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Caen (Cognitive rehabilitation,

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
    • Cognitive rehabilitation
    • Standard Psychological care
    • Caen, Calvados, France
      University Hospital of Caen
    Mar 8, 2022

    Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Ixazomib (NINLARO®) capsules / Matching placebo capsules
    • London, Greater London, United Kingdom
      Royal London Hospital, Barts Health NHS Foundation Trust
    Feb 17, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

    Withdrawn
    • Primary Progressive Multiple Sclerosis
    • +2 more
    • Intranasal Foralumab Solution
    • Placebo
    • (no location specified)
    Feb 14, 2022

    Measuring Active Microglia in Progressive Multiple Sclerosis

    Completed
    • Secondary Progressive Multiple Sclerosis
    • [C11]PK-1195 PET scan
    • New York, New York
      Weill Cornell Medical College
    Jan 14, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2021

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

    Completed
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Dublin, Dublin 4, Ireland
    • +1 more
    Jul 8, 2021

    Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

    Completed
    • Relapsing-remitting Multiple Sclerosis
    • Secondary Progressive Multiple Sclerosis
      • London, United Kingdom
        Imperial College NHS Trust
      Feb 11, 2021

      Phase III Trial With BAF312 in Secondary Progressive Multiple

      Completed
      • Secondary Progressive Multiple Sclerosis
      • Blood Draw
      • CSF collection by lumbar puncture (Optional)
      • Berkeley, California
      • +12 more
      Nov 5, 2020

      Secondary Progressive Multiple Sclerosis Trial in Nottingham (Acceptance Based Telephone Support (ABS+UC))

      Completed
      • Secondary Progressive Multiple Sclerosis
      • Acceptance Based Telephone Support (ABS+UC)
      • Nottingham, Nottinghamshire, United Kingdom
        Queens Medical Centre, Nottingham
      Sep 24, 2020

      Secondary Progressive Multiple Sclerosis Trial in London (Simvastatin)

      Unknown status
      • Secondary Progressive Multiple Sclerosis
      • London, United Kingdom
        Department of Neuroinflammation, UCL Institute of Neurology
      Mar 27, 2020

      Secondary Progressive Multiple Sclerosis Trial in United Kingdom (Amiloride, Riluzole, Fluoxetine)

      Completed
      • Secondary Progressive Multiple Sclerosis
      • Edinburgh, United Kingdom
      • +12 more
      Mar 25, 2020

      Secondary Progressive Multiple Sclerosis Trial in Baltimore (Active cycling, Passive cycling)

      Completed
      • Secondary Progressive Multiple Sclerosis
      • Active cycling
      • Passive cycling
      • Baltimore, Maryland
        Johns Hopkins / Kennedy Krieger Institute
      Mar 18, 2020

      Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Barcelona (XCEL-MC-ALPHA, Placebo)

      Completed
      • Relapsing-Remitting Multiple Sclerosis
      • Secondary Progressive Multiple Sclerosis
      • Barcelona, Spain
        Hospital Vall Hebron
      Jan 15, 2020

      Secondary Progressive Multiple Sclerosis Trial in Chalfont St. Peter, Hammersmith, Brighton (Simvastatin, Placebo)

      Completed
      • Secondary Progressive Multiple Sclerosis
      • Chalfont St. Peter, Buckinghamshire, United Kingdom
      • +2 more
      Nov 21, 2019

      Secondary Progressive Multiple Sclerosis Trial in Ann Arbor (SoluMedrol, Extracorporeal Photopheresis)

      Terminated
      • Secondary Progressive Multiple Sclerosis
      • Ann Arbor, Michigan
        University of Michigan Health Systems
      Aug 8, 2019

      Secondary Progressive Multiple Sclerosis Trial in Isfahan (Rituximab, Glatiramer Acetate)

      Completed
      • Secondary Progressive Multiple Sclerosis
      • Isfahan, Iran, Islamic Republic of
        Kashani Hospital
      May 22, 2019